231 related articles for article (PubMed ID: 6240261)
1. Localization of the complement-component-C3b-binding site and the cofactor activity for factor I in the 38kDa tryptic fragment of factor H.
Alsenz J; Lambris JD; Schulz TF; Dierich MP
Biochem J; 1984 Dec; 224(2):389-98. PubMed ID: 6240261
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H.
Alsenz J; Schulz TF; Lambris JD; Sim RB; Dierich MP
Biochem J; 1985 Dec; 232(3):841-50. PubMed ID: 2936333
[TBL] [Abstract][Full Text] [Related]
3. [Localization of functionally important areas of the regulator protein factor H using monoclonal antibodies].
Schulz TF; Alsenz J; Dierich MP
Wien Klin Wochenschr; 1985 Mar; 97(5):248-52. PubMed ID: 2581372
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the lymphocyte membrane receptor for factor H (beta 1H-globulin) with an antibody to anti-factor H idiotype.
Lambris JD; Ross GD
J Exp Med; 1982 May; 155(5):1400-11. PubMed ID: 6461713
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies against the complement control protein factor H (beta 1 H).
Sim E; Palmer MS; Puklavec M; Sim RB
Biosci Rep; 1983 Dec; 3(12):1119-31. PubMed ID: 6199050
[TBL] [Abstract][Full Text] [Related]
6. A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides.
Lambris JD; Avila D; Becherer JD; Müller-Eberhard HJ
J Biol Chem; 1988 Aug; 263(24):12147-50. PubMed ID: 2969896
[TBL] [Abstract][Full Text] [Related]
7. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
[TBL] [Abstract][Full Text] [Related]
8. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
Sahu A; Isaacs SN; Soulika AM; Lambris JD
J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
[TBL] [Abstract][Full Text] [Related]
9. Limited tryptic cleavage of complement factor H abrogates recognition of sialic acid-containing surfaces by the alternative pathway of complement.
Koistinen V
Biochem J; 1992 Apr; 283 ( Pt 2)(Pt 2):317-9. PubMed ID: 1533511
[TBL] [Abstract][Full Text] [Related]
10. Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor B.
Becherer JD; Alsenz J; Esparza I; Hack CE; Lambris JD
Biochemistry; 1992 Feb; 31(6):1787-94. PubMed ID: 1371073
[TBL] [Abstract][Full Text] [Related]
11. Use of monoclonal antibodies against factor H to investigate the role of a membrane-associated protein antigenically related to H in C3b-receptor function.
Schulz TF; Scheiner O; Alsenz J; Lambris JD; Dierich MP
J Immunol; 1984 Jan; 132(1):392-8. PubMed ID: 6197451
[TBL] [Abstract][Full Text] [Related]
12. Common binding region of complement factors B, H and CR1 on C3b revealed by monoclonal anti-C3d.
Koistinen V; Wessberg S; Leikola J
Complement Inflamm; 1989; 6(4):270-80. PubMed ID: 2527715
[TBL] [Abstract][Full Text] [Related]
13. Isolation of bovine complement factor H.
Mhatre A; Aston WP
Vet Immunol Immunopathol; 1987 Apr; 14(4):357-75. PubMed ID: 2955562
[TBL] [Abstract][Full Text] [Related]
14. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
[TBL] [Abstract][Full Text] [Related]
15. Analysis of gp 140, a C3b-binding membrane component present on Raji cells: a comparison with factor H.
Frade R; Barel M; Krikorian L; Charriaut C
Eur J Immunol; 1984 Jun; 14(6):542-8. PubMed ID: 6234177
[TBL] [Abstract][Full Text] [Related]
16. Mapping of the sites responsible for factor I-cofactor activity for cleavage of C3b and C4b on human C4b-binding protein (C4bp) by deletion mutagenesis.
Fukui A; Yuasa-Nakagawa T; Murakami Y; Funami K; Kishi N; Matsuda T; Fujita T; Seya T; Nagasawa S
J Biochem; 2002 Nov; 132(5):719-28. PubMed ID: 12417021
[TBL] [Abstract][Full Text] [Related]
17. Cell-surface regulation of the human alternative pathway of complement. Sheep but not rabbit erythrocytes express factor I-dependent cofactor activity.
Ezzell JL; Parker CJ
Scand J Immunol; 1992 Jul; 36(1):79-87. PubMed ID: 1535452
[TBL] [Abstract][Full Text] [Related]
18. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
Davis AE; Harrison RA; Lachmann PJ
J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of factor I by diisopropylfluorophosphate. Evidence of conformational changes in factor I induced by C3b and additional studies on the specificity of factor I.
Ekdahl KN; Nilsson UR; Nilsson B
J Immunol; 1990 Jun; 144(11):4269-74. PubMed ID: 2140392
[TBL] [Abstract][Full Text] [Related]
20. Phylogeny of regulatory proteins of the complement system. Isolation and characterization of a C4b/C3b inhibitor and a cofactor from sand bass plasma.
Kaidoh T; Gigli I
J Immunol; 1989 Mar; 142(5):1605-13. PubMed ID: 2918226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]